Prednisolone Renewal

The quality of the drug is confirmed by the international GMP standard.

Indications for use:

Systemic connective tissue diseases (systemic lupus erythematosus, scleroderma, nodular periarteritis, dermatomyositis, rheumatoid arthritis); acute and chronic inflammatory diseases of the joints: gouty and psoriatic arthritis, osteoarthritis (including post-traumatic), polyarthritis (including senile), scapulohumeral periarthritis, ankylosing spondylitis (Bechterew’s disease), juvenile arthritis, Still’s syndrome in adults, bursitis, nonspecific tenosynovitis, synovitis and epicondylitis; acute rheumatism, rheumatic carditis, chorea minor; bronchial asthma, asthmatic status; acute and chronic allergic diseases, incl. allergic reactions to drugs and food products, serum sickness, urticaria, allergic rhinitis, Quincke’s edema, drug rash, hay fever, etc.; skin diseases: pemphigus, psoriasis, eczema, atopic dermatitis (widespread neurodermatitis), contact dermatitis (with damage to a large surface area of ​​the skin), toxicoderma, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell’s syndrome), bullous dermatitis herpetiformis, Stevens-Johnson syndrome; cerebral edema (including against the background of a brain tumor or associated with surgery, radiation therapy or head injury) after preliminary parenteral use; allergic eye diseases (allergic forms of conjunctivitis); Inflammatory eye diseases: sympathetic ophthalmia, severe sluggish anterior and posterior uveitis, optic neuritis; primary or secondary adrenal insufficiency (including the condition after removal of the adrenal glands); congenital adrenal hyperplasia; autoimmune kidney diseases (including acute glomerulonephritis); nephrotic syndrome; subacute thyroiditis; Diseases of the blood and hematopoietic system: agranulocytosis, panmyelopathy, autoimmune hemolytic anemia, lympho- and myeloid leukemia, lymphogranulomatosis, thrombocytopenic purpura, secondary thrombocytopenia in adults, erythroblastopenia (erythroid anemia), congenital (erythroid) hypoplastic anemia; Interstitial lung diseases: acute alveolitis, pulmonary fibrosis, sarcoidosis stages II-III; Tuberculous meningitis, pulmonary tuberculosis, aspiration pneumonia (in combination with specific chemotherapy); berylliosis, Loeffler’s syndrome (not amenable to other therapy); lung cancer (in combination with cytostatics); multiple sclerosis; gastrointestinal diseases: ulcerative colitis, Crohn’s disease, local enteritis; hepatitis, hypoglycemic conditions (hypoglycemia); prevention of transplant rejection reaction during organ transplantation; hypercalcemia against the background of oncological diseases, nausea and vomiting during cytostatic therapy; myeloma disease.

100 tablets of 5 mg